Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.
Sci Adv. 2022 Jul 22;8(29):eabm8780. doi: 10.1126/sciadv.abm8780. Epub 2022 Jul 20.
Sci Adv. 2022.
PMID: 35857848
Free PMC article.
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer.
Molina-Arcas M, Moore C, Rana S, van Maldegem F, Mugarza E, Romero-Clavijo P, Herbert E, Horswell S, Li LS, Janes MR, Hancock DC, Downward J.
Molina-Arcas M, et al. Among authors: mugarza e.
Sci Transl Med. 2019 Sep 18;11(510):eaaw7999. doi: 10.1126/scitranslmed.aaw7999.
Sci Transl Med. 2019.
PMID: 31534020
Free PMC article.
Item in Clipboard
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.
Boumelha J, de Carné Trécesson S, Law EK, Romero-Clavijo P, Coelho MA, Ng KW, Mugarza E, Moore C, Rana S, Caswell DR, Murillo M, Hancock DC, Argyris PP, Brown WL, Durfee C, Larson LK, Vogel RI, Suárez-Bonnet A, Priestnall SL, East P, Ross SJ, Kassiotis G, Molina-Arcas M, Swanton C, Harris R, Downward J.
Boumelha J, et al. Among authors: mugarza e.
Cancer Res. 2022 Oct 4;82(19):3435-3448. doi: 10.1158/0008-5472.CAN-22-0325.
Cancer Res. 2022.
PMID: 35930804
Free PMC article.
Item in Clipboard
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry.
van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, Colliver E, Enfield K, Bah N, Kelly G, Tsang VSK, Mugarza E, Moore C, Hobson P, Levi D, Molina-Arcas M, Swanton C, Downward J.
van Maldegem F, et al. Among authors: mugarza e.
Nat Commun. 2021 Oct 8;12(1):5906. doi: 10.1038/s41467-021-26214-x.
Nat Commun. 2021.
PMID: 34625563
Free PMC article.
Item in Clipboard
CRISPR-Cas9 screening identifies KRAS-induced COX-2 as a driver of immunotherapy resistance in lung cancer.
Boumelha J, de Castro A, Bah N, Cha H, de Carné Trécesson S, Rana S, Tomaschko M, Anastasiou P, Mugarza E, Moore C, Goldstone R, East P, Litchfield K, Lee SH, Molina-Arcas M, Downward J.
Boumelha J, et al. Among authors: mugarza e.
Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2627. Online ahead of print.
Cancer Res. 2024.
PMID: 38635884
Item in Clipboard
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes.
Jilani S, Saco JD, Mugarza E, Pujol-Morcillo A, Chokry J, Ng C, Abril-Rodriguez G, Berger-Manerio D, Pant A, Hu J, Gupta R, Vega-Crespo A, Baselga-Carretero I, Chen JM, Shin DS, Scumpia P, Radu RA, Chen Y, Ribas A, Puig-Saus C.
Jilani S, et al. Among authors: mugarza e.
Nat Commun. 2024 Feb 9;15(1):1244. doi: 10.1038/s41467-024-45221-2.
Nat Commun. 2024.
PMID: 38336975
Free PMC article.
Item in Clipboard
GLP-1 nanomedicine alleviates gut inflammation.
Anbazhagan AN, Thaqi M, Priyamvada S, Jayawardena D, Kumar A, Gujral T, Chatterjee I, Mugarza E, Saksena S, Onyuksel H, Dudeja PK.
Anbazhagan AN, et al. Among authors: mugarza e.
Nanomedicine. 2017 Feb;13(2):659-665. doi: 10.1016/j.nano.2016.08.004. Epub 2016 Aug 20.
Nanomedicine. 2017.
PMID: 27553076
Free PMC article.
Item in Clipboard
Cite
Cite